A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway

“…Consequently, Kelly et al. published the first RC that has incorporated PSMA PET and mpMRI based on the PRIMARY dataset [5]. This novel RC was the first published RC incorporating pre‐biopsy mpMRI and pre‐biopsy PSMA PET.…”